Eckert & Ziegler SEXTER:EUZ +0.06%99 PEG Ratio is 1.34 as of Jul. 06, 2026, which is 45% below its 10-year median of 2.44. GuruFocus rates XTER:EUZ with a GF Score™ of 99/100 and a GF Value™ of €16.26 (Fairly Valued). Among 208 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks better than 67.31% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Eckert & Ziegler SE's PEG Ratio or its related term are showing as below:
XTER:EUZ'
s PEG Ratio Range Over the Past 10 Years
Min: 1.34 Med: 2.44 Max: 21.62
Current: 1.34
During the past 13 years, Eckert & Ziegler SE's highest PEG Ratio was 21.62. The lowest was 1.34. And the median was 2.44.
XTER:EUZ's PEG Ratio is ranked better than 67.31% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.99
vs XTER:EUZ: 1.34
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Eckert & Ziegler SE (XTER:EUZ) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Eckert & Ziegler SE PEG Ratio Related Terms
Eckert & Ziegler SE PEG Ratio Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eckert & Ziegler SE's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Eckert & Ziegler SE (XTER:EUZ) has a PEG Ratio of 1.34 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Eckert & Ziegler SE and its competitors. This is 45% below median its historical median of 2.44. Over the past decade, Eckert & Ziegler SE's PEG Ratio has ranged from 1.34 to 21.62. According to the industry distribution chart, Eckert & Ziegler SE ranks #68 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 32.7%.
Is Eckert & Ziegler SE's PEG Ratio too high?
Eckert & Ziegler SE's current PEG Ratio of 1.34 is 45% below median its 10-year median of 2.44. Over the past 10 years, this metric has ranged from a low of 1.34 to a high of 21.62. The Medical Devices & Instruments industry median PEG Ratio is 1.99. Eckert & Ziegler SE's value of 1.34 is 32.7% below this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #68 out of 208 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #68 out of 208 companies for PEG Ratio. This puts Eckert & Ziegler SE in the upper half of its industry. The industry median PEG Ratio is 1.99. Eckert & Ziegler SE's value of 1.34 is 32.7% below this benchmark. Historically, Eckert & Ziegler SE's own PEG Ratio has ranged from 1.34 to 21.62 over the past decade. While the company's 10-year median is 2.44 vs. the industry median of 1.99, Eckert & Ziegler SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.99, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current PEG Ratio of 1.34 is 32.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current PEG Ratio is 1.34, which is 45% below median its own 10-year median of 2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (XTER:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.26, compared to a current price of €15.90 — trading 2.2% below its estimated fair value. The current PEG Ratio is 1.34, which is 45% below median its 10-year median of 2.44 and 32.7% below the Medical Devices & Instruments industry median of 1.99. Eckert & Ziegler SE's overall GF Score™ is 99/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Eckert & Ziegler SE (XTER:EUZ), the current PEG Ratio is 1.34 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.90 is trading 2.2% below its estimated GF Value™ of €16.26.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for XTER:EUZ:
PEG Ratio: 1.34 (45% below median its 10-year median of 2.44)
GF Value™: €16.26 vs. price of €15.90 (2.2% below fair value)
Industry Position: 32.7% below the Medical Devices & Instruments median (#68 of 208)
No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
99GF Score
Get the complete analysis for XTER:EUZ
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:EUZ has been successfully added to your 
